<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title>Frontiers in Endocrinology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Endocrinol.</abbrev-journal-title>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fendo.2024.1394383</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Association between life&#x2019;s essential 8 and testosterone deficiency in men: NHANES 2011&#x2013;2016</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Cai</surname>
<given-names>Min</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/2671113"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Chen</surname>
<given-names>Jinzao</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<institution>Department of Cardiology, The First Hospital of Putian City</institution>, <addr-line>Putian, Fujian</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Richard Ivell, University of Nottingham, United Kingdom</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Nicola Caretta, University Hospital of Padua, Italy</p>
<p>Yujia Zhang, Centers for Disease Control and Prevention (CDC), United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Jinzao Chen, <email xlink:href="mailto:chen5855@sina.com">chen5855@sina.com</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>03</day>
<month>06</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1394383</elocation-id>
<history>
<date date-type="received">
<day>01</day>
<month>03</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>05</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Cai and Chen</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Cai and Chen</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Serum testosterone is intrinsically associated to cardiovascular disease. Our aim is to explore the relationship between the recently updated cardiovascular health measurement, known as Life&#x2019;s Essential 8 (LE8), and the prevalence of testosterone deficiency (TD) in adult males in the United States.</p>
</sec>
<sec>
<title>Methods</title>
<p>Study data was obtained from the National Health and Nutrition Examination Survey (NHANES) from 2011 to 2016. A weighted multivariate logistic regression model was applied to evaluate the correlation between LE8 and testosterone deficiency. Restricted Cubic Spline (RCS) was employed to explore its non-linear relationship. In addition, a stratified analysis was conducted.</p>
</sec>
<sec>
<title>Results</title>
<p>The final analysis included 2332 participants from NHANES from 2011 to 2016. After adjusting for confounding factors, the odds ratios (ORs) and 95% confidence intervals (CIs) for testosterone deficiency in participants with moderate and higher LE8 scores compared to the lowest LE8 scores were 0.59 (0.38&#x2013;0.92) and 0.38 (0.19&#x2013;0.76), respectively. The results of subgroup analysis showed that LE8 score was significantly associated with TD among young and middle-aged participants.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>A lower LE8 score is related to a higher incidence of testosterone deficiency, especially in young and middle-aged men. Further research is necessary to explore the potential mechanisms between them.</p>
</sec>
</abstract>
<kwd-group>
<kwd>life&#x2019;s essential 8</kwd>
<kwd>testosterone deficiency</kwd>
<kwd>NHANES</kwd>
<kwd>cardiovascular disease</kwd>
<kwd>restricted cubic spline</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="37"/>
<page-count count="7"/>
<word-count count="3044"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Reproduction</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Testosterone, a pivotal hormone that primarily defines male physiology, is synthesized in the labyrinthine interstices of the Leydig cells. This hormone, quintessential in its roles, orchestrates a symphony of biological processes essential to men&#x2019;s health, including sexual function, heart vigor, energy flux, mind clarity, and skeletal strength (<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B3">3</xref>). As such, a decrease or deficiency in male serum testosterone levels can result in multiple organ dysfunction. Moreover, beyond decline and erectile dysfunction, low testosterone levels are also linked to and may exacerbate related metabolic diseases such as depression and osteoporosis, collectively referred to as testosterone deficiency syndrome (<xref ref-type="bibr" rid="B4">4</xref>&#x2013;<xref ref-type="bibr" rid="B6">6</xref>). Given its prevalence, testosterone deficiency is a widespread condition, with the incidence rate notably increasing with age. Projections indicate that this situation will worsen with the increase of average lifespan in the coming decades (<xref ref-type="bibr" rid="B7">7</xref>). Consequently, the global alarm over dwindling testosterone levels is intensifying.</p>
<p>In 2010, the American Heart Association (AHA) unveiled Life&#x2019;s Simple 7 (LS7), a guideline designed to elevate cardiovascular health (CVH) across the populace. This directive advocates for a holistic approach: it emphasizes a nutritious diet, abstaining from tobacco, maintaining a healthy body mass index (BMI), engaging in sufficient physical activity, and ensuring blood pressure, fasting blood sugar, and cholesterol levels remain within desirable ranges (<xref ref-type="bibr" rid="B8">8</xref>). To further improve the evaluation of CVH, the AHA recently introduced Life&#x2019;s Essential 8 (LE8), which advances the original LS7 by incorporating sleep quality indicators and refining the scoring algorithm (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>).</p>
<p>Studies indicate that serum testosterone levels are intricately linked with cardiovascular health, suggesting that bolstering CVH could be a potent strategy to mitigate the impact of serum testosterone deficiency (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>). While prior research has predominantly employed LE8 as a metric for assessing cardiovascular health, it has revealed a significant association between the two. However, to date, no one has previously utilized LE8 to evaluate serum testosterone levels. Therefore, our study sought to delve into the nexus between LE8 and serum testosterone deficiency, aiming to bridge the existing knowledge gap.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="s2_1">
<title>Data and sample sources</title>
<p>NHANES is a systematic cross-sectional health survey project that utilizes a stratified, multi-stage, and probabilistic clustering design. This cross-sectional analysis employed data from the 2011&#x2013;2015 NHANES cycle, with exclusion criteria as follows: (1) individuals who were under 20 years old and Female (n=51,278), (2) those with missing LE8 and serum testosterone data (n=2293), (3) those with fasting weight (wtsaf2yr) =0 (n=3154) and (4) those with covariate-related missing values (n=308). In the end, our investigation encompassed a cohort of 2332 participants (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure&#xa0;1</bold>
</xref>).</p>
</sec>
<sec id="s2_2">
<title>Measurement of LE8</title>
<p>The LE8 scoring system integrates four lifestyle behaviors&#x2014;diet, physical activity, nicotine exposure, and sleep duration&#x2014;with four health indicators: body mass index (BMI), non-high-density lipoprotein cholesterol, blood sugar, and blood pressure. The detailed methodology for computing the LE8 score, utilizing NHANES data, has been thoroughly outlined in prior publications and can be found in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref> (<xref ref-type="bibr" rid="B9">9</xref>). Each of the eight CVH indicators receives a rating on a scale of 0 to 100. The total LE8 score is determined by the unweighted average of these eight indicators, with participants achieving high CVH classified as having an LE8 score of 80&#x2013;100; moderate CVH is defined as ranging from 50 to 79; and low CVH is considered as 0&#x2013;49.</p>
</sec>
<sec id="s2_3">
<title>Assessment of serum testosterone level</title>
<p>According to the guidelines of the American Association of Urologists (AUA), symptoms of TD are identified by serum testosterone levels below 300ng/dL (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>). To minimize biological variability, blood samples were drawn between 8:30 am and 11:30 am after a night of fasting. Subsequently, specimens were frozen on dry ice for immediate use or long-term storage at -70&#xb0;C. To measure the total serum testosterone levels, a competitive electrochemiluminescence immunoassay was utilized on the Elecsys automated analyzer to determine the serum testosterone levels of these samples, with a minimum linear limit of 0.75 ng/dL. For more detailed experimental information, please refer to the following link: <ext-link ext-link-type="uri" xlink:href="https://wwwn.cdc.gov/Nchs/Nhanes/2013&#x2013;2014/TST_H.html">https://wwwn.cdc.gov/Nchs/Nhanes/2013&#x2013;2014/TST_H.html</ext-link>.</p>
</sec>
<sec id="s2_4">
<title>Covariates</title>
<p>In our study, the covariates include several factors previously demonstrated or presumed to affect the relationship between Life&#x2019;s Essential 8 and serum testosterone, including age, gender, race, education, marital status, poverty income ratio (PIR), alcohol consumption, smoking history, hypertension, and diabetes (DM). The detailed classification of these covariates is presented in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Baseline characteristics of participants from the NHANES, 2011&#x2013;2015.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Characteristics</th>
<th valign="top" align="left">Total (N=2332)</th>
<th valign="top" align="left">Non-testosterone deficiency (n=1837)</th>
<th valign="top" align="left">Testosterone <break/>deficiency (n=495)</th>
<th valign="middle" align="left">
<italic>P</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Age, years, mean (SD)</td>
<td valign="top" align="left">47.91&#xb1;0.45</td>
<td valign="top" align="left">46.94&#xb1;0.56</td>
<td valign="top" align="left">51.83&#xb1;0.77</td>
<td valign="top" align="left">&lt;0.0001</td>
</tr>
<tr>
<td valign="top" align="left">Race, n (%)</td>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">0.57</td>
</tr>
<tr>
<td valign="top" align="left">Non-Hispanic White</td>
<td valign="top" align="left">1054 (70.82)</td>
<td valign="top" align="left">807 (70.18)</td>
<td valign="top" align="left">247 (73.39)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">Non-Hispanic Black</td>
<td valign="top" align="left">427 (9.30)</td>
<td valign="top" align="left">343 (9.59)</td>
<td valign="top" align="left">84 (8.09)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">Mexican American</td>
<td valign="top" align="left">298 (7.77)</td>
<td valign="top" align="left">240 (7.95)</td>
<td valign="top" align="left">58 (7.04)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">Other Hispanic</td>
<td valign="top" align="left">225 (5.44)</td>
<td valign="top" align="left">180 (5.60)</td>
<td valign="top" align="left">45 (4.80)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">Other race</td>
<td valign="top" align="left">328 (6.67)</td>
<td valign="top" align="left">267 (6.67)</td>
<td valign="top" align="left">61 (6.68)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">Education, n (%)</td>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">0.58</td>
</tr>
<tr>
<td valign="top" align="left">High school grad or equivalent</td>
<td valign="top" align="left">1210 (56.04)</td>
<td valign="top" align="left">956 (56.77)</td>
<td valign="top" align="left">243 (53.05)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">Less than high school</td>
<td valign="top" align="left">477 (14.77)</td>
<td valign="top" align="left">365 (14.45)</td>
<td valign="top" align="left">112 (16.07)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">Some college or above</td>
<td valign="top" align="left">645 (29.19)</td>
<td valign="top" align="left">505 (28.78)</td>
<td valign="top" align="left">140 (30.87)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">PIR, n (%)</td>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">0.24</td>
</tr>
<tr>
<td valign="top" align="left">&lt;1.3</td>
<td valign="top" align="left">680 (19.51)</td>
<td valign="top" align="left">532 (19.68)</td>
<td valign="top" align="left">148 (18.81)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">1.3-3.5</td>
<td valign="top" align="left">307 (10.84)</td>
<td valign="top" align="left">243 (10.66)</td>
<td valign="top" align="left">64 (11.57)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">&gt;3.5</td>
<td valign="top" align="left">1345 (69.65)</td>
<td valign="top" align="left">1062 (69.66)</td>
<td valign="top" align="left">283 (69.61)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">BMI, n (%)</td>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">&lt;0.0001</td>
</tr>
<tr>
<td valign="top" align="left">&lt;25</td>
<td valign="top" align="left">631 (24.85)</td>
<td valign="top" align="left">573 (28.52)</td>
<td valign="top" align="left">58 (10.00)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">25-29.99</td>
<td valign="top" align="left">884 (38.12)</td>
<td valign="top" align="left">738 (40.90)</td>
<td valign="top" align="left">146 (26.89)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">&#x2265; 30</td>
<td valign="top" align="left">817 (37.02)</td>
<td valign="top" align="left">526 (30.58)</td>
<td valign="top" align="left">291 (63.10)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">Moderate recreational activities, n (%)</td>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">0.18</td>
</tr>
<tr>
<td valign="top" align="left">No</td>
<td valign="top" align="left">1364 (55.46)</td>
<td valign="top" align="left">1053 (54.56)</td>
<td valign="top" align="left">311 (59.13)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">Yes</td>
<td valign="top" align="left">968 (44.54)</td>
<td valign="top" align="left">784 (45.44)</td>
<td valign="top" align="left">184 (40.87)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">Smoking status, n (%)</td>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">&lt;0.0001</td>
</tr>
<tr>
<td valign="top" align="left">Never</td>
<td valign="top" align="left">1087 (48.18)</td>
<td valign="top" align="left">869 (49.48)</td>
<td valign="top" align="left">218 (42.91)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">Former</td>
<td valign="top" align="left">738 (31.42)</td>
<td valign="top" align="left">538 (28.67)</td>
<td valign="top" align="left">200 (42.54)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">Current</td>
<td valign="top" align="left">507 (20.40)</td>
<td valign="top" align="left">430 (21.85)</td>
<td valign="top" align="left">77 (14.55)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">Alcohol drinking, n (%)</td>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">0.002</td>
</tr>
<tr>
<td valign="top" align="left">Never</td>
<td valign="top" align="left">175 (7.02)</td>
<td valign="top" align="left">139 (7.01)</td>
<td valign="top" align="left">36 (7.10)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">Former</td>
<td valign="top" align="left">406 (14.20)</td>
<td valign="top" align="left">287 (12.28)</td>
<td valign="top" align="left">119 (21.97)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">Mild</td>
<td valign="top" align="left">966 (42.35)</td>
<td valign="top" align="left">761 (41.79)</td>
<td valign="top" align="left">205 (44.59)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">Moderate</td>
<td valign="top" align="left">272 (13.19)</td>
<td valign="top" align="left">221 (14.15)</td>
<td valign="top" align="left">51 (9.29)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">Heavy</td>
<td valign="top" align="left">513 (23.24)</td>
<td valign="top" align="left">429 (24.76)</td>
<td valign="top" align="left">84 (17.05)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">Hypertension, n (%)</td>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">&lt;0.0001</td>
</tr>
<tr>
<td valign="top" align="left">No</td>
<td valign="top" align="left">1300 (59.55)</td>
<td valign="top" align="left">1087 (62.29)</td>
<td valign="top" align="left">213 (48.43)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">Yes</td>
<td valign="top" align="left">1032 (40.45)</td>
<td valign="top" align="left">750 (37.71)</td>
<td valign="top" align="left">282 (51.57)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">Diabetes, n (%)</td>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">&lt;0.0001</td>
</tr>
<tr>
<td valign="top" align="left">No</td>
<td valign="top" align="left">1808 (83.10)</td>
<td valign="top" align="left">1503 (86.80)</td>
<td valign="top" align="left">305 (68.12)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">Yes</td>
<td valign="top" align="left">524 (16.90)</td>
<td valign="top" align="left">334 (13.20)</td>
<td valign="top" align="left">190 (31.88)</td>
<td valign="top" align="left"/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>BMI, body mass index; RIP, ratio of family income to poverty.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s2_5">
<title>Statistical analyses</title>
<p>Acknowledging the intricate sampling framework of NHANES, our analysis meticulously incorporated suitable sample weights throughout the study. The chi-square test and Kruskal-Wallis test were utilized to assess if significant differences existed between the different LE8 groups (divided into three categories) and TD. A multivariate logistic regression model was applied to investigate the independent association between LE8 and TD. Within this framework, Model I did not include adjustments for covariates; Model II was specifically adjusted for age, race, education and family annual income; Model III, expanding on Model II, further included adjustments for BMI, moderate recreational activity, smoking, alcohol drinking, hypertension and diabetes. Restricted cubic spline regression was used to explore potential non-linear relationships between the LE8 score, its subscale scores, and TD. To examine subgroups that might be affected by demographic differences, stratified analysis was conducted based on different age, age group, race/ethnicity, poverty rate, and education level. A <italic>p</italic>-value of less than 0.05 was considered to indicate statistical significance.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Baseline characteristics</title>
<p>A total of 2332 eligible participants participated in the NHANES 2011&#x2013;2016 cycle. LE8 is divided into three groups based on scores: low (LE8&lt;50), moderate (50 &#x2264; LE8&lt;80), and high (LE8 &#x2265; 80). The overall prevalence of testosterone deficiency is 21.2%, and participants with testosterone deficiency are typically observed to tend to be older, exhibit a higher BMI, and are more likely to smoke and drink. Additionally, they are more likely to have diabetes and hypertension (<xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>).</p>
<p>Association between LE8 scores and testosterone deficiency.</p>
<p>After adjusting for all confounding variables, the odds ratios (ORs) for testosterone deficiency in the moderate and high CVH groups were 0.59 (95% CI 0.38&#x2013;0.92) and 0.38 (95% CI 0.19&#x2013;0.76), respectively, compared to the low CVH group (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>). In addition, as shown in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>, the RCS analysis results show a negative correlation between LE8 and testosterone deficiency.</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Relationship between LE8 score and testosterone deficiency in the logistic regression models.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" rowspan="2" align="left"/>
<th valign="top" colspan="2" align="left">Model 1</th>
<th valign="top" colspan="2" align="left">Model 2</th>
<th valign="top" colspan="2" align="left">Model 3</th>
</tr>
<tr>
<th valign="top" align="left">OR (95%CI)</th>
<th valign="middle" align="left">
<italic>P</italic> value</th>
<th valign="top" align="left">OR (95% CI)</th>
<th valign="middle" align="left">
<italic>P</italic> value</th>
<th valign="top" align="left">OR (95% CI)</th>
<th valign="middle" align="left">
<italic>P</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<th valign="top" colspan="7" align="left">LE8 score</th>
</tr>
<tr>
<td valign="top" align="left">Low (0-49)</td>
<td valign="top" align="left">Ref</td>
<td valign="top" align="left"/>
<td valign="top" align="left">Ref</td>
<td valign="top" align="left"/>
<td valign="top" align="left">Ref</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">Moderate (50-79)</td>
<td valign="top" align="left">0.36 (0.24,0.52)</td>
<td valign="top" align="left">&lt;0.0001</td>
<td valign="top" align="left">0.37 (0.25,0.55)</td>
<td valign="top" align="left">&lt; 0.0001</td>
<td valign="top" align="left">0.59 (0.38,0.92)</td>
<td valign="top" align="left">0.02</td>
</tr>
<tr>
<td valign="top" align="left">High (80-100)</td>
<td valign="top" align="left">0.14 (0.08,0.25)</td>
<td valign="top" align="left">&lt;0.0001</td>
<td valign="top" align="left">0.15 (0.08,0.27)</td>
<td valign="top" align="left">&lt; 0.0001</td>
<td valign="top" align="left">0.38 (0.19,0.76)</td>
<td valign="top" align="left">0.001</td>
</tr>
<tr>
<td valign="top" align="left">Per 10 points increase</td>
<td valign="top" align="left">0.63 (0.57,0.71)</td>
<td valign="top" align="left">&lt;0.0001</td>
<td valign="top" align="left">0.64 (0.57,0.71)</td>
<td valign="top" align="left">&lt;0.0001</td>
<td valign="top" align="left">0.71 (0.61,0.84)</td>
<td valign="top" align="left">&lt;0.001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Model 1: Adjusted for no covariates.</p>
</fn>
<fn>
<p>Model 2: Adjusted for age, race, education and RIP (ratio of family income to poverty).</p>
</fn>
<fn>
<p>Model 3: Adjust for the variables in Model 2 plus BMI (body mass index), moderate recreational activity, smoking, alcohol drinking, hypertension, diabetes.</p>
</fn>
<fn>
<p>OR, odd ratio.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Restricted cubic spline for relationship of LE8 with risk of life&#x2019;s essential 8 and testosterone deficiency.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1394383-g001.tif"/>
</fig>
</sec>
<sec id="s3_2">
<title>Subgroup analysis</title>
<p>We further conducted subgroup analysis of the study population based on age, whose results manifested that the correlation between LE8 score and TD is significantly enhanced among young and middle-aged participants, especially adolescents (<xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>).</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Results of subgroup analysis <xref ref-type="table-fn" rid="fnT3_1">
<sup>a</sup>
</xref>.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" rowspan="2" align="left">Subgroup</th>
<th valign="top" colspan="3" align="center">LE8 Score group</th>
<th valign="middle" rowspan="2" align="left">
<italic>P</italic> for <break/>interaction</th>
</tr>
<tr>
<th valign="top" align="center">Low (0-49)</th>
<th valign="top" align="left">Moderate (50-79)</th>
<th valign="top" align="left">High (80-100)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Age (years)</td>
<td valign="top" align="center"/>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">0.023</td>
</tr>
<tr>
<td valign="top" align="left">20-39</td>
<td valign="top" align="center">Ref</td>
<td valign="top" align="left">0.42 (0.14,1.02)</td>
<td valign="top" align="left">0.10 (0.02, 0.47)**</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">40-59</td>
<td valign="top" align="center">Ref</td>
<td valign="top" align="left">0.43 (0.20,0.92)*</td>
<td valign="top" align="left">0.47 (0.18,0.98)</td>
<td valign="top" align="left"/>
</tr>
<tr>
<td valign="top" align="left">&#x2265;60</td>
<td valign="top" align="center">Ref</td>
<td valign="top" align="left">0.90 (0.48, 1.68)</td>
<td valign="top" align="left">0.94 (0.38,2.11)</td>
<td valign="top" align="left"/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="fnT3_1">
<label>a</label>
<p>Each stratification was adjusted for age, race, education, BMI (body mass index), moderate recreational activity, smoking, alcohol drinking, hypertension, diabetes and RIP (ratio of family income to poverty). OR, odds ratio; CI, confidence interval.</p>
<p>* means <italic>P</italic> &lt; 0.05, ** means <italic>P</italic> &lt; 0.01.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>This research leveraged data from the NHANES in the United States, with the objective of exploring the linkage between LE8 and testosterone deficiency among adult male individuals. The findings reveal a linear relationship between LE8 and testosterone deficiency, where an increase in LE8 score levels is associated with a gradual decrease in the incidence of testosterone deficiency. This relationship holds even after adjusting for other potential confounding factors, where the LE8 score remains significantly negatively correlated with testosterone deficiency. Furthermore, subgroup analysis demonstrated that a significant decrease in the proportion of individuals with testosterone deficiency is primarily observed in the population aged 60 and below.</p>
<p>As the American Heart Association has recently updated its assessment tool for quantifying cardiovascular health (CVH), Life&#x2019;s Essential 8 (LE8) has emerged as a scoring system that not only offers enhanced sensitivity to individual differences but also highlights the social determinants of maintaining or improving both health and mental health aspects of CVH (<xref ref-type="bibr" rid="B10">10</xref>). Currently, the application and value of Life&#x2019;s Essential 8 are widely recognized as critical indicators for evaluating cardiovascular health (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>). Moreover, research has closely linked LE8 to conditions such as chronic kidney disease, non-alcoholic fatty liver disease, and periodontitis (<xref ref-type="bibr" rid="B17">17</xref>&#x2013;<xref ref-type="bibr" rid="B19">19</xref>). Yet, research on LE8 and testosterone deficiency remains unexplored. Previous studies have shown that serum testosterone has a direct impact on myocardial and vascular structure and function, as well as on risk factors for cardiovascular disease (<xref ref-type="bibr" rid="B20">20</xref>). At present, testosterone exhibits several potential mechanisms through which it can affect cardiovascular risk, including reducing lipoprotein (a), improving cardiac function and aerobic function, promoting coronary vasodilation, reducing fat content, and potentially reducing or delaying the risk of or delay in the development of diabetes (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>). In addition, many studies have confirmed that serum testosterone deficiency is an independent risk factor for cardiovascular disease and all-cause mortality (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>). A recent Mendelian genetic analysis suggests that genes associated with elevated serum endogenous testosterone levels may also be linked to the risk of myocardial infarction (<xref ref-type="bibr" rid="B25">25</xref>). A meta-analysis of drug epidemiology studies in 2018 showed that testosterone treatment can reduce the risk of myocardial infarction (<xref ref-type="bibr" rid="B26">26</xref>). Two prospective cohort studies have demonstrated a negative correlation between baseline serum endogenous testosterone concentration and the risk of atrial fibrillation in middle-aged and elderly men (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B27">27</xref>). Moreover, the relationship between hypogonadism and metabolic disorders is multifactorial and bidirectional, and is associated with disruptions of the hypothalamic pituitary gonadal axis (<xref ref-type="bibr" rid="B28">28</xref>). The decrease in serum testosterone levels leads to an increase in lipoprotein lipase expression and an increase in visceral adipose tissue (VAT) accumulation. This accumulation of VAT leads to the release of pro-inflammatory cytokines (TNF-&#x3b1;, IL-1&#x3b2;), and leptin, which directly inhibits the HPG axis and the interstitial cells of the testes, responsible for the production of serum testosterone (<xref ref-type="bibr" rid="B29">29</xref>). Additionally, the accumulation of VAT can also lead to an increase in aromatase levels, causing insulin resistance and a reduction in myogenesis via androgen receptor-mediated pathways (<xref ref-type="bibr" rid="B30">30</xref>). Considering that previous studies have identified a close correlation between serum testosterone and cardiovascular disease, this emphasizes the necessity of investigating the relationship between the recently updated cardiovascular health measurement method, Life&#x2019;s Essential 8 (LE8), and the prevalence of testosterone deficiency in adult males in the United States.</p>
<p>There are several reasons that can explain the association between LE8 and serum testosterone. Firstly, LE8 encompasses four health behaviors: Healthy Eating Index (HEI-2015), physical activity, nicotine exposure, and sleep health. Research by Kurniawan et&#xa0;al. revealed that testosterone-related dietary patterns (characterized by frequent consumption of bread and pastries, dairy products, desserts, dining out, and the low-frequency consumption of homemade foods, noodles, and dark green vegetables) are predictive of low testosterone levels and decreased gonadal function (<xref ref-type="bibr" rid="B31">31</xref>). Additionally, Hern&#xe1;ndez-P&#xe9;rez et&#xa0;al. discovered that sleep deprivation (&#x2264; 6 hours) is associated with higher T concentrations in males, while in middle-aged males (aged 41&#x2013;64), increased sleep time is linked to lower T concentrations. In women, a type &#x2018;J&#x2019; association between sleep time and low T concentration was noted only in the middle-aged category (<xref ref-type="bibr" rid="B32">32</xref>). Moreover, Steeves et&#xa0;al. reported that compared to men who engage in 25 minutes or less of physical activity per day, men who participate in more than 65 minutes of physical activity per day experience a significant reduction in the risk of maintaining normal testosterone levels&#x2014;by half (<xref ref-type="bibr" rid="B33">33</xref>). These findings align with the health behavior score of LE8.</p>
<p>On the other hand, the LE8 encompasses four health factors: body mass index, blood lipids, blood sugar, and blood pressure. Hypogonadism frequently accompanies metabolic complications like obesity and diabetes; a reduction or absence of testosterone can precipitate metabolic disorders by elevating visceral lipids and worsening insulin resistance (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>). Furthermore, the interplay between hypogonadism and metabolic disorders is recognized as bidirectional, affecting both functional and delayed forms of hypogonadism (<xref ref-type="bibr" rid="B29">29</xref>); Hyperglycemia can directly trigger a reduction in testosterone synthesis within Leydig cells by activating the TLR4-mediated oxidative stress pathway (<xref ref-type="bibr" rid="B36">36</xref>). Additionally, a high-quality meta-analysis by Brand et&#xa0;al. demonstrated a significant correlation between low testosterone levels and hypertriglyceridemia, noting the greatest degree of association in non-overweight males (<xref ref-type="bibr" rid="B37">37</xref>). Thus, the elements included in the LE8 score are intrinsically linked to the risk of serum testosterone levels. LE8 functions as an all-encompassing and readily deployable evaluation instrument in clinical environments, encouraging adherence to healthful behaviors and optimal health metrics. Upholding optimal cardiovascular health (CVH) indicators could represent a viable preventive and management approach to lessen the impact of serum testosterone deficiency and other chronic conditions, including cardiovascular disease.</p>
<p>This study boasts several advantages. Firstly, it utilized a large sample of nationally representative American adults, enabling the research findings to be generalized to a broader population. Secondly, through conducting stratified analysis, it unveiled a strong correlation between LE8 and serum testosterone levels across diverse population groups. However, the current research also faces certain limitations. Firstly, given that too many observations have been excluded, it is challenging to ascertain whether the research data originates from representative samples. Secondly, given the cross-sectional nature of this study, establishing the causal relationship between LE8 and testosterone deficiency proves challenging. Thirdly, the measurement of serum testosterone levels is susceptible to various factors. The current best method for evaluating hypogonadism is to calculate free testosterone. Although rigorous controls were applied during the measurement process, these factors may nonetheless influence the outcomes. Finally, considering the complexity of the sampling design, we used the degree of freedom for measurement data as the number of primary sampling units (PSUs) minus the number of strata, instead of the usual number of observations minus one. This adjustment has a significant impact on the calculation of standard errors and on statistical testing.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<title>Conclusion</title>
<p>This cross-sectional study demonstrated a negative correlation between the LE8 score and testosterone deficiency. The findings suggest that LE8 offers potential beneficial effects as a viable and effective method for improving serum testosterone levels. To validate these findings, additional prospective longitudinal studies are necessary in the future.</p>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding author/s.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The manuscript presents research on animals that do not require ethical approval for their study.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>MC: Data curation, Methodology, Writing &#x2013; original draft. JC: Supervision, Validation, Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fendo.2024.1394383/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fendo.2024.1394383/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Image_1.tif" id="SF1" mimetype="image/tiff">
<label>Supplementary Figure&#xa0;1</label>
<caption>
<p>Flow chart of participants selection.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tyagi</surname> <given-names>V</given-names>
</name>
<name>
<surname>Scordo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yoon</surname> <given-names>RS</given-names>
</name>
<name>
<surname>Liporace</surname> <given-names>FA</given-names>
</name>
<name>
<surname>Greene</surname> <given-names>LW</given-names>
</name>
</person-group>. <article-title>Revisiting the role of testosterone: Are we missing something</article-title>? <source>Rev Urol</source>. (<year>2017</year>) <volume>19</volume>:<fpage>16</fpage>&#x2013;<lpage>24</lpage>. doi: <pub-id pub-id-type="doi">10.3909/riu0716</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muller</surname> <given-names>MN</given-names>
</name>
</person-group>. <article-title>Testosterone and reproductive effort in male primates</article-title>. <source>Hormones Behav</source>. (<year>2017</year>) <volume>91</volume>:<fpage>36</fpage>&#x2013;<lpage>51</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.yhbeh.2016.09.001</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shigehara</surname> <given-names>K</given-names>
</name>
<name>
<surname>Izumi</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kadono</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Mizokami</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Testosterone and bone health in men: A narrative review</article-title>. <source>J Clin Med</source>. (<year>2021</year>) <volume>10</volume>:<fpage>530</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/jcm10030530</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saad</surname> <given-names>F</given-names>
</name>
<name>
<surname>R&#xf6;hrig</surname> <given-names>G</given-names>
</name>
<name>
<surname>von Haehling</surname> <given-names>S</given-names>
</name>
<name>
<surname>Traish</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Testosterone deficiency and testosterone treatment in older men</article-title>. <source>Gerontology</source>. (<year>2017</year>) <volume>63</volume>:<page-range>144&#x2013;56</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000452499</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Genetically predicted sex hormone levels and health outcomes: phenome-wide Mendelian randomization investigation</article-title>. <source>Int J Epidemiol</source>. (<year>2022</year>) <volume>51</volume>:<page-range>1931&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/ije/dyac036</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kasarinaite</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sinton</surname> <given-names>M</given-names>
</name>
<name>
<surname>Saunders</surname> <given-names>PTK</given-names>
</name>
<name>
<surname>Hay</surname> <given-names>DC</given-names>
</name>
</person-group>. <article-title>The influence of sex hormones in liver function and disease</article-title>. <source>Cells</source>. (<year>2023</year>) <volume>12</volume>:<fpage>1604</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cells12121604</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Halpern</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Brannigan</surname> <given-names>RE</given-names>
</name>
</person-group>. <article-title>Testosterone deficiency</article-title>. <source>Jama</source>. (<year>2019</year>) <volume>322</volume>:<fpage>1116</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1001/jama.2019.9290</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lloyd-Jones</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Hong</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Labarthe</surname> <given-names>D</given-names>
</name>
<name>
<surname>Mozaffarian</surname> <given-names>D</given-names>
</name>
<name>
<surname>Appel</surname> <given-names>LJ</given-names>
</name>
<name>
<surname>Van Horn</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association&#x2019;s strategic Impact Goal through 2020 and beyond</article-title>. <source>Circulation</source>. (<year>2010</year>) <volume>121</volume>:<fpage>586</fpage>&#x2013;<lpage>613</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.109.192703</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lloyd-Jones</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Allen</surname> <given-names>NB</given-names>
</name>
<name>
<surname>Anderson</surname> <given-names>CAM</given-names>
</name>
<name>
<surname>Black</surname> <given-names>T</given-names>
</name>
<name>
<surname>Brewer</surname> <given-names>LC</given-names>
</name>
<name>
<surname>Foraker</surname> <given-names>RE</given-names>
</name>
<etal/>
</person-group>. <article-title>Life&#x2019;s essential 8: updating and enhancing the american heart association&#x2019;s construct of cardiovascular health: A presidential advisory from the american heart association</article-title>. <source>Circulation</source>. (<year>2022</year>) <volume>146</volume>:<page-range>e18&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/CIR.0000000000001078</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lloyd-Jones</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Ning</surname> <given-names>H</given-names>
</name>
<name>
<surname>Labarthe</surname> <given-names>D</given-names>
</name>
<name>
<surname>Brewer</surname> <given-names>L</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>G</given-names>
</name>
<name>
<surname>Rosamond</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Status of cardiovascular health in US adults and children using the american heart association&#x2019;s new &#x201c;Life&#x2019;s essential 8&#x201d; Metrics: prevalence estimates from the national health and nutrition examination survey (NHANES), 2013 through 2018</article-title>. <source>Circulation</source>. (<year>2022</year>) <volume>146</volume>:<page-range>822&#x2013;35</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.122.060911</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gyawali</surname> <given-names>P</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Heilbronn</surname> <given-names>LK</given-names>
</name>
<name>
<surname>Vincent</surname> <given-names>AD</given-names>
</name>
<name>
<surname>Jenkins</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Januszewski</surname> <given-names>AS</given-names>
</name>
<etal/>
</person-group>. <article-title>Higher serum sex hormone-binding globulin levels are associated with incident cardiovascular disease in men</article-title>. <source>J Clin Endocrinol Metab</source>. (<year>2019</year>) <volume>104</volume>:<page-range>6301&#x2013;15</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/jc.2019-01317</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeller</surname> <given-names>T</given-names>
</name>
<name>
<surname>Schnabel</surname> <given-names>RB</given-names>
</name>
<name>
<surname>Appelbaum</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ojeda</surname> <given-names>F</given-names>
</name>
<name>
<surname>Berisha</surname> <given-names>F</given-names>
</name>
<name>
<surname>Schulte-Steinberg</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Low testosterone levels are predictive for incident atrial fibrillation and ischaemic stroke in men, but protective in women - results from the FINRISK study</article-title>. <source>Eur J Prev Cardiol</source>. (<year>2018</year>) <volume>25</volume>:<page-range>1133&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/2047487318778346</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mulhall</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Trost</surname> <given-names>LW</given-names>
</name>
<name>
<surname>Brannigan</surname> <given-names>RE</given-names>
</name>
<name>
<surname>Kurtz</surname> <given-names>EG</given-names>
</name>
<name>
<surname>Redmon</surname> <given-names>JB</given-names>
</name>
<name>
<surname>Chiles</surname> <given-names>KA</given-names>
</name>
<etal/>
</person-group>. <article-title>Evaluation and management of testosterone deficiency: AUA guideline</article-title>. <source>J Urol</source>. (<year>2018</year>) <volume>200</volume>:<page-range>423&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.juro.2018.03.115</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Increased risk of testosterone deficiency is associated with the systemic immune-inflammation index: a population-based cohort study</article-title>. <source>Front Endocrinol</source>. (<year>2022</year>) <volume>13</volume>:<elocation-id>974773</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2022.974773</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>J</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Magnussen</surname> <given-names>CG</given-names>
</name>
<etal/>
</person-group>. <article-title>Association of the American Heart Association&#x2019;s new &#x201c;Life&#x2019;s Essential 8&#x201d; with all-cause and cardiovascular disease-specific mortality: prospective cohort study</article-title>. <source>BMC Med</source>. (<year>2023</year>) <volume>21</volume>:<fpage>116</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12916-023-02824-8</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petermann-Rocha</surname> <given-names>F</given-names>
</name>
<name>
<surname>Deo</surname> <given-names>S</given-names>
</name>
<name>
<surname>Celis-Morales</surname> <given-names>C</given-names>
</name>
<name>
<surname>Ho</surname> <given-names>FK</given-names>
</name>
<name>
<surname>Bahuguna</surname> <given-names>P</given-names>
</name>
<name>
<surname>McAllister</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>An opportunity for prevention: associations between the life&#x2019;s essential 8 score and cardiovascular incidence using prospective data from UK biobank</article-title>. <source>Curr problems Cardiol</source>. (<year>2023</year>) <volume>48</volume>:<fpage>101540</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cpcardiol.2022.101540</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Yi</surname> <given-names>J</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>X</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Associations between life&#x2019;s essential 8 and non-alcoholic fatty liver disease among US adults</article-title>. <source>J Trans Med</source>. (<year>2022</year>) <volume>20</volume>:<fpage>616</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12967-022-03839-0</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ren</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Associations between life&#x2019;s essential 8 and chronic kidney disease</article-title>. <source>J Am Heart Assoc</source>. (<year>2023</year>) <volume>12</volume>:<elocation-id>e030564</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/JAHA.123.030564</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>X</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>C</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>F</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>S</given-names>
</name>
<name>
<surname>Song</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Association between life&#x2019;s essential 8 and periodontitis: a population-based study</article-title>. <source>BMC Oral Health</source>. (<year>2024</year>) <volume>24</volume>:<fpage>19</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12903-023-03816-z</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cittadini</surname> <given-names>A</given-names>
</name>
<name>
<surname>Isidori</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Salzano</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Testosterone therapy and cardiovascular diseases</article-title>. <source>Cardiovasc Res</source>. (<year>2022</year>) <volume>118</volume>:<page-range>2039&#x2013;57</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/cvr/cvab241</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gagliano-Juc&#xe1;</surname> <given-names>T</given-names>
</name>
<name>
<surname>Basaria</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Testosterone replacement therapy and cardiovascular risk</article-title>. <source>Nat Rev Cardiol</source>. (<year>2019</year>) <volume>16</volume>:<page-range>555&#x2013;74</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41569-019-0211-4</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname> <given-names>TH</given-names>
</name>
<name>
<surname>Kelly</surname> <given-names>DM</given-names>
</name>
</person-group>. <article-title>Randomized controlled trials - mechanistic studies of testosterone and the cardiovascular system</article-title>. <source>Asian J andrology</source>. (<year>2018</year>) <volume>20</volume>:<page-range>120&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4103/aja.aja_6_18</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shores</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Biggs</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Arnold</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>NL</given-names>
</name>
<name>
<surname>Longstreth</surname> <given-names>WT</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Kizer</surname> <given-names>JR</given-names>
</name>
<etal/>
</person-group>. <article-title>Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the cardiovascular health study</article-title>. <source>J Clin Endocrinol Metab</source>. (<year>2014</year>) <volume>99</volume>:<page-range>2061&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/jc.2013-3576</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Cumming</surname> <given-names>RG</given-names>
</name>
<name>
<surname>Naganathan</surname> <given-names>V</given-names>
</name>
<name>
<surname>Blyth</surname> <given-names>FM</given-names>
</name>
<name>
<surname>Le Couteur</surname> <given-names>DG</given-names>
</name>
<name>
<surname>Hirani</surname> <given-names>V</given-names>
</name>
<etal/>
</person-group>. <article-title>Temporal changes in androgens and estrogens are associated with all-cause and cause-specific mortality in older men</article-title>. <source>J Clin Endocrinol Metab</source>. (<year>2016</year>) <volume>101</volume>:<page-range>2201&#x2013;10</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/jc.2016-1025</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname> <given-names>S</given-names>
</name>
<name>
<surname>Au Yeung</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>JV</given-names>
</name>
<name>
<surname>Burgess</surname> <given-names>S</given-names>
</name>
<name>
<surname>Schooling</surname> <given-names>CM</given-names>
</name>
</person-group>. <article-title>Association of genetically predicted testosterone with thromboembolism, heart failure, and myocardial infarction: mendelian randomisation study in UK Biobank</article-title>. <source>BMJ</source>. (<year>2019</year>) <volume>364</volume>:<fpage>l476</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/bmj.l476</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corona</surname> <given-names>G</given-names>
</name>
<name>
<surname>Rastrelli</surname> <given-names>G</given-names>
</name>
<name>
<surname>Di Pasquale</surname> <given-names>G</given-names>
</name>
<name>
<surname>Sforza</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mannucci</surname> <given-names>E</given-names>
</name>
<name>
<surname>Maggi</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Testosterone and cardiovascular risk: meta-analysis of interventional studies</article-title>. <source>J sexual Med</source>. (<year>2018</year>) <volume>15</volume>:<page-range>820&#x2013;38</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jsxm.2018.04.641</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Magnani</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Moser</surname> <given-names>CB</given-names>
</name>
<name>
<surname>Murabito</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Sullivan</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>N</given-names>
</name>
<name>
<surname>Ellinor</surname> <given-names>PT</given-names>
</name>
<etal/>
</person-group>. <article-title>Association of sex hormones, aging, and atrial fibrillation in men: the Framingham Heart Study</article-title>. <source>Circulation. Arrhythmia electrophysiology</source>. (<year>2014</year>) <volume>7</volume>:<page-range>307&#x2013;12</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1161/CIRCEP.113.001322</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Louters</surname> <given-names>M</given-names>
</name>
<name>
<surname>Pearlman</surname> <given-names>M</given-names>
</name>
<name>
<surname>Solsrud</surname> <given-names>E</given-names>
</name>
<name>
<surname>Pearlman</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Functional hypogonadism among patients with obesity, diabetes, and metabolic syndrome</article-title>. <source>Int J impotence Res</source>. (<year>2022</year>) <volume>34</volume>:<page-range>714&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41443-021-00496-7</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pivonello</surname> <given-names>R</given-names>
</name>
<name>
<surname>Menafra</surname> <given-names>D</given-names>
</name>
<name>
<surname>Riccio</surname> <given-names>E</given-names>
</name>
<name>
<surname>Garifalos</surname> <given-names>F</given-names>
</name>
<name>
<surname>Mazzella</surname> <given-names>M</given-names>
</name>
<name>
<surname>de Angelis</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Metabolic disorders and male hypogonadotropic hypogonadism</article-title>. <source>Front Endocrinol</source>. (<year>2019</year>) <volume>10</volume>:<elocation-id>345</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2019.00345</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname> <given-names>R</given-names>
</name>
<name>
<surname>Artaza</surname> <given-names>JN</given-names>
</name>
<name>
<surname>Taylor</surname> <given-names>WE</given-names>
</name>
<name>
<surname>Gonzalez-Cadavid</surname> <given-names>NF</given-names>
</name>
<name>
<surname>Bhasin</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway</article-title>. <source>Endocrinology</source>. (<year>2003</year>) <volume>144</volume>:<page-range>5081&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/en.2003-0741</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kurniawan</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Hsu</surname> <given-names>CY</given-names>
</name>
<name>
<surname>Chao</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Paramastri</surname> <given-names>R</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>HA</given-names>
</name>
<name>
<surname>Lai</surname> <given-names>PC</given-names>
</name>
<etal/>
</person-group>. <article-title>Association of testosterone-related dietary pattern with testicular function among adult men: A cross-sectional health screening study in Taiwan</article-title>. <source>Nutrients</source>. (<year>2021</year>) <volume>13</volume>:<fpage>259</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu13010259</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hern&#xe1;ndez-P&#xe9;rez</surname> <given-names>JG</given-names>
</name>
<name>
<surname>Taha</surname> <given-names>S</given-names>
</name>
<name>
<surname>Torres-S&#xe1;nchez</surname> <given-names>LE</given-names>
</name>
<name>
<surname>Villasante-Tezanos</surname> <given-names>A</given-names>
</name>
<name>
<surname>Milani</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Baillargeon</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Association of sleep duration and quality with serum testosterone concentrations among men and women: NHANES 2011&#x2013;2016</article-title>. <source>Andrology</source>. (<year>2023</year>) <volume>12</volume>:<fpage>518</fpage>&#x2013;<lpage>26</lpage>.  doi: <pub-id pub-id-type="doi">10.1111/andr.13496</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steeves</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Fitzhugh</surname> <given-names>EC</given-names>
</name>
<name>
<surname>Bradwin</surname> <given-names>G</given-names>
</name>
<name>
<surname>McGlynn</surname> <given-names>KA</given-names>
</name>
<name>
<surname>Platz</surname> <given-names>EA</given-names>
</name>
<name>
<surname>Joshu</surname> <given-names>CE</given-names>
</name>
</person-group>. <article-title>Cross-sectional association between physical activity and serum testosterone levels in US men: results from NHANES 1999&#x2013;2004</article-title>. <source>Andrology</source>. (<year>2016</year>) <volume>4</volume>:<page-range>465&#x2013;72</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/andr.12169</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corona</surname> <given-names>G</given-names>
</name>
<name>
<surname>Bianchini</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sforza</surname> <given-names>A</given-names>
</name>
<name>
<surname>Vignozzi</surname> <given-names>L</given-names>
</name>
<name>
<surname>Maggi</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Hypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men</article-title>. <source>Hormones</source>. (<year>2015</year>) <volume>14</volume>:<page-range>569&#x2013;78</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.14310/horm.2002</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krysiak</surname> <given-names>R</given-names>
</name>
<name>
<surname>Kowalcze</surname> <given-names>K</given-names>
</name>
<name>
<surname>Okopie&#x144;</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Hypothalamic-pituitary-gonadal axis and sexual functioning in metformin-treated men after discontinuation of testosterone replacement therapy: A pilot study</article-title>. <source>J Clin Pharm Ther</source>. (<year>2021</year>) <volume>46</volume>:<page-range>1764&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jcpt.13528</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karpova</surname> <given-names>T</given-names>
</name>
<name>
<surname>de Oliveira</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Naas</surname> <given-names>H</given-names>
</name>
<name>
<surname>Priviero</surname> <given-names>F</given-names>
</name>
<name>
<surname>Nunes</surname> <given-names>KP</given-names>
</name>
</person-group>. <article-title>Blockade of Toll-like receptor 4 (TLR4) reduces oxidative stress and restores phospho-ERK1/2 levels in Leydig cells exposed to high glucose</article-title>. <source>Life Sci</source>. (<year>2020</year>) <volume>245</volume>:<fpage>117365</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.lfs.2020.117365</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brand</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Rovers</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Yeap</surname> <given-names>BB</given-names>
</name>
<name>
<surname>Schneider</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Tuomainen</surname> <given-names>TP</given-names>
</name>
<name>
<surname>Haring</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies</article-title>. <source>PloS One</source>. (<year>2014</year>) <volume>9</volume>:<elocation-id>e100409</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0100409</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>